Yu Zhou
2018
In 2018, Yu Zhou earned a total compensation of $182.4K as Co, CEO of GenExosome at Avalon GloboCare Corp., a 716% increase compared to previous year.
Compensation breakdown
| Salary | $182,356 |
|---|---|
| Total | $182,356 |
Zhou received $182.4K in salary, accounting for 100% of the total pay in 2018.
Rankings
In 2018, Yu Zhou's compensation ranked 13,788th out of 14,244 executives tracked by ExecPay. In other words, Zhou earned more than 3.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,788 out of 14,244 | 3rd |
Division Manufacturing | 5,580 out of 5,765 | 3rd |
Major group Chemicals And Allied Products | 2,077 out of 2,128 | 2nd |
Industry group Drugs | 1,776 out of 1,817 | 2nd |
Industry Biological Products, Except Diagnostic Substances | 338 out of 339 | 0th |
Source: SEC filing on June 17, 2019.
Zhou's colleagues
We found three more compensation records of executives who worked with Yu Zhou at Avalon GloboCare Corp. in 2018.